Get the app!
Back to Trades
Other3

Avalyn Pharma Inc.

AVLN

Total Value
$NaN

Company Information

Company Name
Avalyn Pharma Inc.
Ticker Symbol
AVLN
CIK
0001540171

Insider Information

Role
Insider
Location
BOSTON, MA

Filing Details

Filing Date
Apr 29, 2026
Transaction Date
Apr 29, 2026
Accession Number
0001193125-26-193145
Form Type
3

Footnotes

  1. (F1)The Series A Preferred Shares, Series B Preferred Shares, Series C-1 Preferred Shares, Series C-2 Preferred Shares, and Series D Preferred Shares are convertible on a 1-for-1 basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration, and have no expiration date.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.